Acacia Research Corporation (Nasdaq:ACTG) announced today that a subsidiary has acquired patents for heart valve technology from a major medical device company.
“Acacia is rapidly becoming the leader in technology licensing and we continue to grow our base of future revenues by adding new patent portfolios”
"As Acacia's licensing success grows, an increasing number of major companies are selecting us as their partner for the licensing of their patented technologies," commented Paul Ryan, Acacia Chairman and CEO. "Acacia is rapidly becoming the leader in technology licensing and we continue to grow our base of future revenues by adding new patent portfolios," concluded Mr. Ryan.
Decoding the genetic roots of stroke and heart attack